Godavari Biorefineries Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹558Cr
- +4.7% YoY
- −1.1% QoQ
- Net profit
- −₹19Cr
- Q1 FY26: −₹16 Cr
- Margin
- 0.1%
- −1 pp YoY
- −14.9 pp QoQ
What the Q1 FY27 call signalled
1 of 4 strong
The short version
Expecting strong growth in bio-based specialty chemicals with sales projected to increase from INR190 crores in the current quarter to INR240 crores per quarter post INR25 crores debottlenecking investment by early FY28. Bio-based specialty chemicals business shows strong growth with revenue increasing QoQ from INR141 crores to INR190 crores, expected to reach INR240 crores per quarter post-debottlenecking by early FY28.
From Godavari Biorefineries Ltd's Q1 FY27 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Expecting strong growth in bio-based specialty chemicals with sales projected to increase from INR190 crores in the current quarter to INR240 crores per quarter post INR25 crores debottlenecking investment by early FY28.
- Operating cash flows in the chemical sector expected to improve and sustain due to better gross margins and debottlenecking benefits.
- Ethanol demand anticipated to grow with E20 rollout continuing and introduction of E85 and E100 fuels, supported by government policies and flex-fuel vehicles.
- Investing in additional maize/grain front-end capacity to optimize product mix and improve ethanol production flexibility.
2 more points from Godavari Biorefineries Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Godavari Biorefineries Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Immediate investment of INR 25 crores planned for debottlenecking the bio-based specialty chemical business to meet growing demand, expected to complete by early FY28.
- Exploring front-end investments in maize/grain preparation facilities to utilize idle fermentation and distillation capacity, potentially adding 160 KLPD fungible capacity within the existing 800 KLPD distillery.
- Committed to spending INR 20 crores over the next 30-33 months on drug discovery, including safety trials for a novel anticancer molecule.
2 more points from Godavari Biorefineries Ltd's call on capex
Create a free account to keep reading this call
Fundraising & Capital Structure
See what Godavari Biorefineries Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The company is experiencing strong and growing demand in its bio-based specialty chemicals business both domestically and internationally.
- They are expecting sales of about INR 190 crores in the current quarter, up from INR 169 crores reported last quarter.
- Post completion of a planned INR 25 crore debottlenecking investment (expected by the start of FY28), they anticipate bio-based specialty chemicals business to reach around INR 240 crores per quarter.
- There is significant customer interest fueled by global supply tightness and increased focus on supply chain reliability.
Godavari Biorefineries Ltd — Quarterly revenue & net profit
Godavari Biorefineries Ltd Q1 FY27 results — key figures
| ₹ Cr | Q1 FY27 | Q1 FY26 | YoY | Q4 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 558 | 533 | +4.7% | 564 | -1.1% |
| Operating profit (EBITDA) | 1 | 6 | -83.3% | 86 | -98.8% |
| Operating margin | 0.1% | 1.1% | -1 pp | 15% | -14.9 pp |
| Profit before tax | -26 | -22 | — | 70 | -137.1% |
| Net profit (PAT) | -19 | -16 | — | 53 | -135.8% |
| EPS (₹) | -3.78 | -3.13 | — | 10.33 | -136.6% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹549 Cr, net loss ₹15 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Godavari Biorefineries's management said in earlier quarters
Potential multibaggers · Q2 FY27
This quarter's potential multibaggers
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Godavari Biorefineries Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Godavari Biorefineries Ltd Q1 FY27 results?
Expecting strong growth in bio-based specialty chemicals with sales projected to increase from INR190 crores in the current quarter to INR240 crores per quarter post INR25 crores debottlenecking investment by early FY28. Bio-based specialty chemicals business shows strong growth with revenue increasing QoQ from INR141 crores to INR190 crores, expected to reach INR240 crores per quarter post-debottlenecking by early FY28.
What is Godavari Biorefineries Ltd share price analysis?
Godavari Biorefineries Ltd currently shows a below-average growth signal. The stock trades at a P/E of 42.5 with a market cap of ₹1,233 Cr. Investors should review the full earnings analysis for detailed insights.
Is Godavari Biorefineries Ltd planning capital expenditure?
Immediate investment of INR 25 crores planned for debottlenecking the bio-based specialty chemical business to meet growing demand, expected to complete by early FY28.
Keep Godavari Biorefineries Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
